{"title":"Early Mycosis Fungoides","authors":"S. Lessin","doi":"10.5580/13c0","DOIUrl":null,"url":null,"abstract":"Stuart R. Lessin M.D. is an investigative dermatologist with a research and clinical interest in cutaneous oncology. He has investigated the etiologic role of oncogenic viruses in cutaneous T cell lymphoma (CTCL) and the molecular mechanisms underlying oncogene and tumor suppressor gene expression in development and tumor progression of CTCL. He has developed techniques for the molecular diagnosis of lymphoproliferative skin diseases based on Tcell receptor (TCR) gene expression. Since 2000, Dr. Lessin has served as Director of Dermatology at the Fox Chase Cancer Center (FCCC) in","PeriodicalId":161194,"journal":{"name":"The Internet Journal of Dermatology","volume":"32 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Internet Journal of Dermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5580/13c0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Stuart R. Lessin M.D. is an investigative dermatologist with a research and clinical interest in cutaneous oncology. He has investigated the etiologic role of oncogenic viruses in cutaneous T cell lymphoma (CTCL) and the molecular mechanisms underlying oncogene and tumor suppressor gene expression in development and tumor progression of CTCL. He has developed techniques for the molecular diagnosis of lymphoproliferative skin diseases based on Tcell receptor (TCR) gene expression. Since 2000, Dr. Lessin has served as Director of Dermatology at the Fox Chase Cancer Center (FCCC) in
Stuart R. Lessin医学博士是一名调查皮肤科医生,对皮肤肿瘤学有研究和临床兴趣。他研究了致瘤病毒在皮肤T细胞淋巴瘤(CTCL)中的病因学作用,以及癌基因和肿瘤抑制基因表达在CTCL发生和肿瘤进展中的分子机制。他开发了基于t细胞受体(TCR)基因表达的淋巴增生性皮肤病分子诊断技术。自2000年以来,Lessin博士一直担任Fox Chase Cancer Center (FCCC)皮肤科主任